6,961 Shares in Bath & Body Works, Inc. $BBWI Bought by Park Avenue Securities LLC

Park Avenue Securities LLC acquired a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 6,961 shares of the company’s stock, valued at approximately $209,000.

Several other institutional investors have also modified their holdings of the stock. T. Rowe Price Investment Management Inc. lifted its stake in Bath & Body Works by 7.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock valued at $334,029,000 after buying an additional 781,681 shares in the last quarter. Victory Capital Management Inc. lifted its position in shares of Bath & Body Works by 14,732.0% in the first quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock valued at $206,119,000 after acquiring an additional 6,752,274 shares in the last quarter. Alliancebernstein L.P. lifted its position in shares of Bath & Body Works by 4.7% in the first quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company’s stock valued at $164,397,000 after acquiring an additional 243,611 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of Bath & Body Works by 267.8% in the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock worth $121,073,000 after acquiring an additional 2,907,506 shares during the last quarter. Finally, GMT Capital Corp increased its position in shares of Bath & Body Works by 7.3% during the first quarter. GMT Capital Corp now owns 3,737,700 shares of the company’s stock worth $113,327,000 after purchasing an additional 255,600 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $25.66 on Thursday. The company has a market capitalization of $5.29 billion, a P/E ratio of 7.61, a P/E/G ratio of 0.88 and a beta of 1.52. The company has a 50 day simple moving average of $28.65 and a 200-day simple moving average of $29.53. Bath & Body Works, Inc. has a 1 year low of $24.93 and a 1 year high of $41.87.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting the consensus estimate of $0.37. The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm’s revenue for the quarter was down .8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 23.74%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on BBWI. UBS Group decreased their price objective on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a report on Friday, August 29th. JPMorgan Chase & Co. raised their price target on shares of Bath & Body Works from $40.00 to $46.00 and gave the stock an “overweight” rating in a research note on Monday, July 28th. Morgan Stanley dropped their price objective on shares of Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating for the company in a research note on Friday, September 12th. Telsey Advisory Group reiterated an “outperform” rating and issued a $38.00 price objective on shares of Bath & Body Works in a report on Thursday, August 28th. Finally, Barclays boosted their target price on Bath & Body Works from $30.00 to $32.00 and gave the stock an “equal weight” rating in a report on Friday, August 29th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $39.69.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.